Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'BEHAVIORAL SYMPTOMS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 102 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Schneider, LS; Tariot, PN; Lyketsos, CG; Dagerman, KS; Davis, KL; Davis, S; Hsiao, JK; Jeste, DV; Katz, IR; Olin, JT; Pollock, BG; Rabins, PV; Rosenheck, RA; Small, GW; Lebowitz, B; Lieberman, JA
      National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) - Alzheimer disease trial methodology

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    2. Kerbeshian, J; Burd, L; Avery, K
      Pharmacotherapy of autism: A review and clinical approach

      JOURNAL OF DEVELOPMENTAL AND PHYSICAL DISABILITIES
    3. Posey, DJ; Guenin, KD; Kohn, AE; Swiezy, NB; McDougle, CJ
      A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    4. Sourial, R; McCusker, J; Cole, M; Abrahamowicz, M
      Agitation in demented patients in an acute care hospital: Prevalence, disruptiveness, and staff burden

      INTERNATIONAL PSYCHOGERIATRICS
    5. Petit-Carrie, S; Salamon, M; Tison, SM; Poisot, C; Bouzigon, E; Stessin, C
      The 3-to 4-year-old child's health checkup: results of the screening testsundergone in 1999 by physicians of Mother and Infant Welfare in the Gironde region

      ARCHIVES DE PEDIATRIE
    6. Tursz, A
      The contribution of epidemiology to the knowledge of mental disorders in childhood.

      ARCHIVES DE PEDIATRIE
    7. Monteiro, IM; Boksay, I; Auer, SR; Torossian, C; Ferris, SH; Reisberg, B
      Addition of a frequency-weighted score to the Behavioral Pathology in Alzheimer's disease Rating Scale: the BEHAVE-AD-FW: methodology and reliability

      EUROPEAN PSYCHIATRY
    8. Malone, RP; Cater, J; Sheikh, RM; Choudhury, MS; Delaney, MA
      Olanzapine versus haloperidol in children with autistic disorder: An open pilot study

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    9. Howard, R; Ballard, C; O'Brien, J; Burns, A
      Guidelines for the management of agitation in dementia

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    10. Simard, M; van Reekum, R
      Dementia with lewy bodies in Down's syndrome

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    11. Tsolaki, M
      Evaluation of tiapride in agitated elderly outpatients: an open study

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    12. Cummings, JL; McPherson, S
      Neuropsychiatric assessment of Alzheimer's disease and related dementias

      AGING-CLINICAL AND EXPERIMENTAL RESEARCH
    13. Michalowski, M; Ketzer, C; Daudt, L; Rohde, LA
      Emotional and behavioral symptoms in children with acute leukemia

      HAEMATOLOGICA
    14. Christopoulos, A
      From 'captive' agonism to insurmountable antagonism: Demonstrating the power of analytical pharmacology

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    15. Remington, G; Sloman, L; Konstantareas, M; Parker, K; Gow, R
      Clomipramine versus haloperidol in the treatment of autistic disorder: A double-blind, placebo-controlled, crossover study

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    16. Chen, NC; Bedair, HS; McKay, B; Bowers, MB; Mazure, C
      Clozapine in the treatment of aggression in an adolescent with autistic disorder

      JOURNAL OF CLINICAL PSYCHIATRY
    17. Mintzer, JE
      Underlying mechanisms of psychosis and aggression in patients with Alzheimer's disease

      JOURNAL OF CLINICAL PSYCHIATRY
    18. Volkmar, FR
      Pharmacological interventions in autism: Theoretical and practical issues

      JOURNAL OF CLINICAL CHILD PSYCHOLOGY
    19. Perry, KW; Nisenbaum, LK; George, CA; Shannon, HE; Felder, CC; Bymaster, FP
      The muscarinic agonist xanomeline increases monoamine release and immediate early gene expression in the rat prefrontal cortex

      BIOLOGICAL PSYCHIATRY
    20. Coyle, J; Kershaw, P
      Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: Effects on the course of Alzheimer's disease

      BIOLOGICAL PSYCHIATRY
    21. Casarett, DJ; Inouye, SK
      Diagnosis and management of delirium near the end of life

      ANNALS OF INTERNAL MEDICINE
    22. Bedford, S; Melzer, D; Guralnik, J
      Problem behavior in the last year of life: Prevalence, risks, and care receipt in older Americans

      JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
    23. Cras, P
      Recent developments in Alzheimer's disease

      ACTA CLINICA BELGICA
    24. van Soest, M; Wormstall, H
      Acute delirium in elderly patients, a neglected interdisciplinary problem

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    25. Barrash, J; Tranel, D; Anderson, SW
      Acquired personality disturbances associated with bilateral damage to the ventromedial prefrontal region

      DEVELOPMENTAL NEUROPSYCHOLOGY
    26. Farlow, MR; Cyrus, PA
      Metrifonate therapy in Alzheimer's disease: A pooled analysis of four randomized, double-blind, placebo-controlled trials

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    27. Shinosaki, K; Nishikawa, T; Takeda, M
      Neurobiological basis of behavioral and psychological symptoms in dementiaof the Alzheimer type

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    28. Jeste, DV; Finkel, SI
      Psychosis of Alzheimer's disease and related dementias - Diagnostic criteria for a distinct syndrome

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    29. McDougle, CJ; Scahill, L; McCracken, JT; Aman, MG; Tierney, E; Arnold, LE; Freeman, BJ; Martin, A; McGough, JJ; Cronin, P; Posey, DJ; Riddle, MA; Ritz, L; Swiezy, NB; Vitiello, B; Volkmar, FR; Votolato, NA; Walson, P
      Research Units on Pediatric Psychopharmacology (RUPP) autism network - Background and rationale for an initial controlled study of risperidone

      CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA
    30. Negron, AE; Reichman, WE
      Risperidone in the treatment of patients with Alzheimer's disease with negative symptoms

      INTERNATIONAL PSYCHOGERIATRICS
    31. Devanand, DP
      Conventional neuroleptics in dementia

      INTERNATIONAL PSYCHOGERIATRICS
    32. Gillberg, C
      Typical neuroleptics in child and adolescent psychiatry

      EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
    33. Buitelaar, JK; Willemsen-Swinkels, SHN
      Medication treatment in subjects with autistic spectrum disorders

      EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
    34. Shankar, KK; Orrell, MW
      Detecting and managing depression and anxiety in people with dementia

      CURRENT OPINION IN PSYCHIATRY
    35. Shannon, HE; Rasmussen, K; Bymaster, FP; Hart, JC; Peters, SC; Swedberg, MDB; Jeppesen, L; Sheardown, MJ; Sauerberg, P; Fink-Jensen, A
      Xanomeline, an M-1/M-4 preferring muscarinic cholinergic receptor agonist,produces antipsychotic-like activity in rats and mice

      SCHIZOPHRENIA RESEARCH
    36. Kaufer, DI; Cummings, JL; Ketchel, P; Smith, V; MacMillan, A; Shelley, T; Lopez, OL; DeKosky, ST
      Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory

      JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
    37. Caligiuri, MP; Peavy, G
      An instrumental study of the relationship between extrapyramidal signs andpsychosis in Alzheimer's disease

      JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
    38. De Deyn, PP; Katz, IR
      Control of aggression and agitation in patients with dementia: Efficacy and safety of risperidone

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    39. Chung, JA; Cummings, JL
      Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease - Characteristics and treatment

      NEUROLOGIC CLINICS
    40. Defilippi, JL; Crismon, ML
      Antipsychotic agents in patients with dementia

      PHARMACOTHERAPY
    41. Aman, MG; Langworthy, KS
      Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders

      JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS
    42. Thal, LJ; Forrest, M; Loft, H; Mengel, H
      Lu 25-109, a muscarinic agonist, fails to improve cognition in Alzheimer'sdisease

      NEUROLOGY
    43. Tariot, PN; Solomon, PR; Morris, JC; Kershaw, P; Lilienfeld, S; Ding, C
      A 5-month, randomized, placebo-controlled trial of galantamine in AD

      NEUROLOGY
    44. Knopman, DS
      Part VI. Primary drug therapies for Alzheimer's disease

      DM DISEASE-A-MONTH
    45. Jeste, DV; Okamoto, A; Napolitano, J; Kane, JM; Martinez, RA
      Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone

      AMERICAN JOURNAL OF PSYCHIATRY
    46. Cummings, JL
      Cholinesterase inhibitors: A new class of psychotropic compounds

      AMERICAN JOURNAL OF PSYCHIATRY
    47. Battin, J; Lacombe, D; Taine, L; Goizet, C
      Williams syndrome and behavioral phenotypes in human microdeletion syndromes

      BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE
    48. Frisoni, GB; Rozzini, L; Gozzetti, A; Binetti, G; Zanetti, O; Bianchetti, A; Trabucchi, M; Cummings, JL
      Behavioral syndromes in Alzheimer's disease: Description and correlates

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    49. Cummings, JL; Jeste, DV
      Alzheimer's disease and its management in the year 2010

      PSYCHIATRIC SERVICES
    50. Malone, RP; Sheikh, R; Zito, JM
      Novel antipsychotic medications in the treatment of children and adolescents

      PSYCHIATRIC SERVICES
    51. Kurz, A
      The impact of antidementia drugs on real life

      ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
    52. Brodaty, H
      Realistic expectations for the management of Alzheimer's disease

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    53. Devanand, DP
      The interrelations between psychosis, behavioral disturbance, and depression in Alzheimer disease

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    54. Levy, ML; Cummings, JL; Kahn-Rose, R
      Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease

      GERONTOLOGY
    55. Schneider, LS
      Pharmacologic management of psychosis in dementia

      JOURNAL OF CLINICAL PSYCHIATRY
    56. De Deyn, PP; Rabheru, K; Rasmussen, A; Bocksberger, JP; Dautzenberg, PLJ; Eriksson, S; Lawlor, BA
      A randomized trial of risperidone, placebo, and haloperidol for behavioralsymptoms of dementia

      NEUROLOGY
    57. Shannon, HE; Hart, JC; Bymaster, FP; Calligaro, DO; Delapp, NW; Mitch, CH; Ward, JS; Fink-Jensen, A; Sauerberg, P; Jeppesen, L; Sheardown, MJ; Swedberg, MDB
      Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    58. Christopoulos, A; Parsons, AM; El-Fakahany, EE
      Pharmacological analysis of the novel mode of interaction between xanomeline and the M-1 muscarinic acetylcholine receptor

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    59. Francis, PT; Palmer, AM; Snape, M; Wilcock, GK
      The cholinergic hypothesis of Alzheimer's disease: a review of progress - Reply

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    60. Richards, SS; Hendrie, HC
      Diagnosis, management, and treatment of Alzheimer disease - A guide for the internist

      ARCHIVES OF INTERNAL MEDICINE
    61. Burke, WJ; Roccaforte, WH; Wengel, SP
      Treating visual hallucinations with donepezil

      AMERICAN JOURNAL OF PSYCHIATRY
    62. CUMMINGS JL; BACK C
      THE CHOLINERGIC HYPOTHESIS OF NEUROPSYCHIATRIC SYMPTOMS IN ALZHEIMERS-DISEASE

      The American journal of geriatric psychiatry
    63. CALIGIURI MP; ROCKWELL E; JESTE DV
      EXTRAPYRAMIDAL SIDE-EFFECTS IN PATIENTS WITH ALZHEIMERS-DISEASE TREATED WITH LOW-DOSE NEUROLEPTIC MEDICATION

      The American journal of geriatric psychiatry
    64. RAO V; LYKETSOS CG
      DELUSIONS IN ALZHEIMERS-DISEASE - A REVIEW

      The Journal of neuropsychiatry and clinical neurosciences
    65. NICOLSON R; AWAD G; SLOMAN L
      AN OPEN TRIAL OF RISPERIDONE IN YOUNG AUTISTIC-CHILDREN

      Journal of the American Academy of Child and Adolescent Psychiatry
    66. KLOSZEWSKA I
      INCIDENCE AND RELATIONSHIP BETWEEN BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS IN ALZHEIMERS-DISEASE

      International journal of geriatric psychiatry
    67. FINKEL SI
      ANTIPSYCHOTICS - OLD AND NEW

      Clinics in geriatric medicine
    68. BUITELAAR JK; VANDERGAAG RJ; VANDERHOEVEN J
      BUSPIRONE IN THE MANAGEMENT OF ANXIETY AND IRRITABILITY IN CHILDREN WITH PERVASIVE DEVELOPMENTAL DISORDERS - RESULTS OF AN OPEN-LABEL STUDY

      The Journal of clinical psychiatry
    69. PETIT H; BAKCHINE S; DUBOIS B; LAURENT B; MONTAGNE B; TOUCHON J; ROBERT P; VELLAS B; VETEL JM; COGNEAU J; LAMESLEE RM; SORBE G
      CONSENSUS STATEMENT FROM A GROUP OF FRENCH EXPERTS ON ALZHEIMERS-DISEASE DIAGNOSIS AND PHARMACOLOGICAL TREATMENT

      Revue neurologique
    70. Watson, J; Brough, S; Coldwell, MC; Gager, T; Ho, M; Hunter, AJ; Jerman, J; Middlemiss, DN; Riley, GJ; Brown, AM
      Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors

      BRITISH JOURNAL OF PHARMACOLOGY
    71. KAUFER DI; CUMMINGS JL; CHRISTINE D; BRAY T; CASTELLON S; MASTERMAN D; MACMILLAN A; KETCHEL P; DEKOSKY ST
      ASSESSING THE IMPACT OF NEUROPSYCHIATRIC SYMPTOMS IN ALZHEIMERS-DISEASE - THE NEUROPSYCHIATRIC INVENTORY CAREGIVER DISTRESS SCALE

      Journal of the American Geriatrics Society
    72. VICTOROFF J; MACK WJ; NIELSON KA
      PSYCHIATRIC COMPLICATIONS OF DEMENTIA - IMPACT ON CAREGIVERS

      Dementia and geriatric cognitive disorders
    73. GAUTHIER S
      UPDATE ON DIAGNOSTIC METHODS, NATURAL-HISTORY AND OUTCOME VARIABLES IN ALZHEIMERS-DISEASE

      Dementia and geriatric cognitive disorders
    74. KAUFER D
      BEYOND THE CHOLINERGIC HYPOTHESIS - THE EFFECT OF METRIFONATE AND OTHER CHOLINESTERASE-INHIBITORS ON NEUROPSYCHIATRIC SYMPTOMS IN ALZHEIMERS-DISEASE

      Dementia and geriatric cognitive disorders
    75. HARTEVELD EM; BUITELAAR JK
      AUTISM - ROLE OF DRUG-TREATMENT AND A GUIDE TO ITS USE

      CNS DRUGS
    76. PERRY R; PATAKI C; MUNOZSILVA DM; ARMENTEROS J; SILVA RR
      RISPERIDONE IN CHILDREN AND ADOLESCENTS WITH PERVASIVE DEVELOPMENTAL DISORDER - PILOT TRIAL AND FOLLOW-UP

      Journal of child and adolescent psychopharmacology
    77. CAMPBELL M; ARMENTEROS JL; MALONE RP; ADAMS PB; EISENBERG ZW; OVERALL JE
      NEUROLEPTIC-RELATED DYSKINESIAS IN AUTISTIC-CHILDREN - A PROSPECTIVE,LONGITUDINAL-STUDY

      Journal of the American Academy of Child and Adolescent Psychiatry
    78. GREER S; MOOREY S
      ADJUVANT PSYCHOLOGICAL THERAPY FOR CANCER-PATIENTS

      Palliative medicine
    79. HAYASHI T; YOKOTA N; TAKAHASHI T; TAWARA Y; NISHIKAWA T; YANO T; FURUTANI M; FUJIKAWA T; HORIGUCHI J; YAMAWAKI S
      BENEFITS OF TRAZODONE AND MIANSERIN FOR PATIENTS WITH LATE-LIFE CHRONIC-SCHIZOPHRENIA AND TARDIVE-DYSKINESIA - AN ADD-ON, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

      International clinical psychopharmacology
    80. FINDLING RL; MAXWELL K; SCOTESEWOJTILA L; HUANG J; YAMASHITA T; WIZNITZER M
      HIGH-DOSE PYRIDOXINE AND MAGNESIUM ADMINISTRATION IN CHILDREN WITH AUTISTIC DISORDER - AN ABSENCE OF SALUTARY EFFECTS IN A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

      Journal of autism and developmental disorders
    81. SMALL GW; RABINS PV; BARRY PP; BUCKHOLTZ NS; DEKOSKY ST; FERRIS SH; FINKEL SI; GWYTHER LP; KHACHATURIAN ZS; LEBOWITZ BD; MCRAE TD; MORRIS JC; OAKLEY F; SCHNEIDER LS; STREIM JE; SUNDERLAND T; TERI LA; TUNE LE
      DIAGNOSIS AND TREATMENT OF ALZHEIMER-DISEASE AND RELATED DISORDERS - CONSENSUS STATEMENT OF THE AMERICAN-ASSOCIATION-FOR-GERIATRIC-PSYCHIATRY, THE ALZHEIMERS-ASSOCIATION, AND THE AMERICAN-GERIATRICS-SOCIETY

      JAMA, the journal of the American Medical Association
    82. KOOPMANS RTCM; VANROSSUM JM; VANDENHOOGEN HJM; HEKSTER YA; WILLEKENSBOGAERS MAJH; VANWEEL C
      PSYCHOTROPIC-DRUG NSE IN A GROUP OF DUTCH NURSING-HOME PATIENTS WITH DEMENTIA - MANY USERS, LONG-TERM USE, BUT LOW-DOSES

      Pharmacy world & science
    83. SANCHEZ LE; CAMPBELL M; SMALL AM; CUEVA JE; ARMENTEROS JL; ADAMS PB
      A PILOT-STUDY OF CLOMIPRAMINE IN YOUNG AUTISTIC-CHILDREN

      Journal of the American Academy of Child and Adolescent Psychiatry
    84. CAMPBELL M; SCHOPLER E; CUEVA JE; HALLIN A
      TREATMENT OF AUTISTIC DISORDER

      Journal of the American Academy of Child and Adolescent Psychiatry
    85. ORRELL M; BEBBINGTON P
      PSYCHOSOCIAL STRESS AND ANXIETY IN SENILE DEMENTIA

      Journal of affective disorders
    86. TARIOT PN
      TREATMENT STRATEGIES FOR AGITATION AND PSYCHOSIS IN DEMENTIA

      The Journal of clinical psychiatry
    87. ANTAO V; MADDOCKS A; STREET E; SIBERT JR
      A CASE-CONTROL STUDY OF SOMATIC AND BEHAVIORAL SYMPTOMS IN SEXUALLY ABUSED BOYS

      Archives of Disease in Childhood
    88. HAYASHI T; YAMAWAKI S; NISHIKAWA T; JESTE DV
      USAGE AND SIDE-EFFECTS OF NEUROLEPTICS IN ELDERLY JAPANESE PATIENTS

      The American journal of geriatric psychiatry
    89. CAMPBELL M; CUEVA JE
      PSYCHOPHARMACOLOGY IN CHILD AND ADOLESCENT-PSYCHIATRY - A REVIEW OF THE PAST 7 YEARS .1.

      Journal of the American Academy of Child and Adolescent Psychiatry
    90. WOLFF PH; DAWIT Y; ZERE B
      THE SOLOMUNA ORPHANAGE - A HISTORICAL SURVEY

      Social science & medicine
    91. QUINTANA H; BIRMAHER B; STEDGE D; LENNON S; FREED J; BRIDGE J; GREENHILL L
      USE OF METHYLPHENIDATE IN THE TREATMENT OF CHILDREN WITH AUTISTIC DISORDER

      Journal of autism and developmental disorders
    92. MIYAMORI T; MIYAMORI K; HASEGAWA T; TOKUDA K; YAMAMOTO Y
      EXPANDED CAVUM SEPTI PELLUCIDI AND CAVUM VERGAE ASSOCIATED WITH BEHAVIORAL SYMPTOMS RELIEVED BY A STEREOTAXIC PROCEDURE - CASE-REPORT

      Surgical neurology
    93. SANCHEZ LE; ADAMS PB; UYSAL S; HALLIN A; CAMPBELL M; SMALL AM
      A COMPARISON OF LIVE AND VIDEOTAPE RATINGS - CLOMIPRAMINE AND HALOPERIDOL IN AUTISM

      Psychopharmacology bulletin
    94. ROCKWELL E; JACKSON E; VILKE G; JESTE DV
      A STUDY OF DELUSIONS IN A LARGE COHORT OF ALZHEIMERS-DISEASE PATIENTS

      The American journal of geriatric psychiatry
    95. KOTILA M; HOKKANEN L; LAAKSONEN R; VALANNE L
      LONG-TERM PROGNOSIS AFTER LEFT TUBEROTHALAMIC INFARCTION - A STUDY OF7 CASES

      Cerebrovascular diseases
    96. HOMMA A; ISHII T; NIINA R
      RELATIONSHIP OF BEHAVIORAL COMPLICATIONS AND SEVERITY OF DEMENTIA IN JAPANESE ELDERLY PERSONS WITH DEMENTIA

      Alzheimer disease and associated disorders
    97. SPENCER EK; CAMPBELL M
      CHILDREN WITH SCHIZOPHRENIA - DIAGNOSIS, PHENOMENOLOGY, AND PHARMACOTHERAPY

      Schizophrenia bulletin
    98. GONZALEZ NM; CAMPBELL M; SMALL AM; SHAY J; BLUHM LD; ADAMS PB; FOLTZ RL
      NALTREXONE PLASMA-LEVELS, CLINICAL-RESPONSE AND EFFECT ON WEIGHT IN AUTISTIC-CHILDREN

      Psychopharmacology bulletin
    99. GONZALEZ NM; CAMPBELL M; SMALL AM; SHAY J; BLUHM LD; ADAMS PB; FOLTZ RL
      NALTREXONE PLASMA-LEVELS, CLINICAL-RESPONSE AND EFFECT ON WEIGHT IN AUTISTIC-CHILDREN

      Psychopharmacology bulletin
    100. FORSELL Y; JORM AF; WINBLAD B
      VARIATION IN PSYCHIATRIC AND BEHAVIORAL SYMPTOMS AT DIFFERENT STAGES OF DEMENTIA - DATA FROM PHYSICIANS EXAMINATIONS AND INFORMANTS REPORTS

      Dementia


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 20:58:17